We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Novel Sensory Chip for Rapid Detection of Illegal Drugs

By LabMedica International staff writers
Posted on 22 May 2018
Print article
Image: A scanning electron microscope image shows the surface of a new chemical sensing chip. The surface consists of gold nanoparticles (small bright dots) that have been deposited over silver nanoparticles (light gray regions) to form a hybrid gold-silver nanostructure (Photo courtesy of Nan Zhang, University at Buffalo).
Image: A scanning electron microscope image shows the surface of a new chemical sensing chip. The surface consists of gold nanoparticles (small bright dots) that have been deposited over silver nanoparticles (light gray regions) to form a hybrid gold-silver nanostructure (Photo courtesy of Nan Zhang, University at Buffalo).
A novel sensory chip is expected to serve as the basis for a low-cost diagnostic platform for the rapid detection of illegal drugs such as cocaine.

The chip represents an expanded application for surface‐enhanced Raman spectroscopy (SERS). Raman spectroscopy exploits the inelastic scattering (so-called “Raman” scattering) phenomena to detect spectral signatures of important disease progression biomarkers, including lipids, proteins, and amino acids. A surface enhanced Raman spectroscopy technique enables determination of the conformation of molecules at low micromolar concentrations. Unlike conventional surface enhanced Raman spectroscopy, this approach does not require immobilization of molecules.

Investigators at the University at Buffalo (NY, USA) fabricated a superabsorbing metasurface chip with hybrid silver-gold nanostructures. A two‐step process of deposition plus subsequent thermal annealing was developed to shrink the gap among the metallic nanoparticles with no top‐down lithography technology involved. Because of the light trapping strategy enabled by the hybrid silver-gold metasurface structure, the excitation laser energy could be localized at the edges of the nanoparticles more efficiently, resulting in enhanced sensing resolution. Since more hot spots were excited over a given area with higher density of small nanoparticles, the spatial distribution of the localized field was more uniform, resulting in superior performance for potential quantitative sensing of drugs such as cocaine and chemicals with thiol groups. Furthermore, the final coating of a second gold nanoparticle layer improved the reliability of the chip, which was shown to be effective after 12 months storage at ambient temperature.

The investigators wrote in the May 7, 2018, online edition of the journal Small Methods that the chip had the potential to be integrated into a handheld, portable device for detecting drugs in biological samples such as blood, breath, urine, or saliva.

"Currently, there is a great demand for on-site drug testing," said senior author Dr. Qiaoqiang Gan, associate professor of electrical engineering at the University at Buffalo. "The high-performance chip we designed was able to detect cocaine within minutes in our experiments. It's also inexpensive: It can be produced using raw materials that cost around 10 cents, and the fabrication techniques we used are also low-cost. In the future, we are hoping to also use this technology to detect other drugs, including marijuana. "The widening legalization of marijuana raises a lot of societal issues, including the need for a system to quickly test drivers for drug use."

Related Links:
University at Buffalo

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TRAb Immunoassay
Chorus TRAb
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.